Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Staccato® Loxapine Treatment of Agitation in Bipolar Disorder Patients (AMDC-004-302)

This study has been completed.
Information provided by:
Alexza Pharmaceuticals, Inc. Identifier:
First received: July 23, 2008
Last updated: October 22, 2008
Last verified: October 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2008
  Primary Completion Date: October 2008 (Final data collection date for primary outcome measure)